ArticleMolecular medicine reports2016

CDKN3 expression is negatively associated with pathological tumor stage and CDKN3 inhibition promotes cell survival in hepatocellular carcinoma.

Wei Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.